Alimentary Pharmacology & Therapeutics

Review article: practical management of inflammatory bowel disease patients taking immunomodulators
pp. 1-16(16)
Authors: SIEGEL, C. A.; SANDS, B. E.

Review article: the changing epidemiology of hepatocellular carcinoma in Canada
pp. 17-22(6)
Authors: DYER, Z.; PELTEKIAN, K.; VELDHUYZEN VAN ZANTEN, S.

Review article: angiogenesis soluble factors as liver disease markers
pp. 23-30(8)
Authors: SALCEDO, X.; MEDINA, J.; SANZ-CAMENO, P.; GARCÍA-BUEY, L.; MARTÍN-VILCHEZ, S.; MORENO-OTERO, R.

Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth
pp. 31-35(5)
Authors: LAURITANO, E. C.; GABRIELLI, M.; LUPASCU, A.; SANTOLIQUIDO, A.; NUCERA, G.; SCARPELLINI, E.; VINCENTI, F.; CAMMAROTA, G.; FLORE, R.; POLA, P.; GASBARRINI, G.; GASBARRINI, A.

Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients
pp. 37-44(8)
Authors: TROTTER, J. F.; OSBORNE, J. C.; HELLER, M.; CHRISTIANS, U.

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
pp. 45-49(5)
Authors: GATTA, L.; ZULLO, A.; PERNA, F.; RICCI, C.; DE FRANCESCO, V.; TAMPIERI, A.; BERNABUCCI, V.; CAVINA, M.; HASSAN, C.; IERARDI, E.; MORINI, S.; VAIRA, D.

Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy
pp. 51-57(7)
Authors: DATTA, S.; CHATTOPADHYAY, S.; PATRA, R.; DE, R.; RAMAMURTHY, T.; HEMBRAM, J.; CHOWDHURY, A.; BHATTACHARYA, S. K.; BERG, D. E.; NAIR, G. B.; MUKHOPADHYAY, A. K.

Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod
pp. 59-65(7)
Authors: TOUGAS, G.; EARNEST, D. L.; CHEN, Y.; VANDERKOY, C.; ROJAVIN, M.

Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status
pp. 67-74(8)
Authors: FURUTA, T.; SHIRAI, N.; SUGIMOTO, M.; NAKAMURA, A.; OKUDAIRA, K.; KAJIMURA, M.; HISHIDA, A.

South Asian origin as a risk factor for GERD
pp. 75-76(2)

Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome
pp. 76-77(2)

Polyethylene glycol for constipation: Author's reply
pp. 77-78(2)